Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 250Carcinoma, Non-Small-Cell Lung 86Carcinoma, Renal Cell 62Neoplasm Metastasis 53Neoplasms 51Prostatic Neoplasms 35Lung Neoplasms 32Uveal Melanoma 29Pancreatic Neoplasms 28Carcinoma, Hepatocellular 25Brain Neoplasms 24Colorectal Neoplasms 23Sarcoma 22Breast Neoplasms 20Squamous Cell Carcinoma of Head and Neck 18Small Cell Lung Carcinoma 18Kidney Neoplasms 18Skin Neoplasms 17Diabetes Mellitus, Insulin-Dependent, 12 17Carcinoma, Transitional Cell 17Ovarian Neoplasms 15Urinary Bladder Neoplasms 14Triple Negative Breast Neoplasms 14Mesothelioma 13Glioblastoma 13Uterine Cervical Neoplasms 12Recurrence 12Multiple Myeloma 11Lymphoma 11Clear-cell metastatic renal cell carcinoma 11

Interventions

Exercise 249Resistance Training 32Surveys and Questionnaires 22High-Intensity Interval Training 20Walking 15Diet 14Preoperative Exercise 13Methods 13Exercise Therapy 13Control Groups 12Standard of Care 11Nutritional Status 9Counseling 8Nutrition Assessment 7methyl hydroxyethyl cellulose 5Motivational Interviewing 5Fitness Trackers 5Diet Therapy 5Physical Therapy Modalities 4Nutritional Support 4Interviews as Topic 4Educational Status 4Cognitive Behavioral Therapy 4Behavior Therapy 4Wearable Electronic Devices 3Therapeutics 3Rehabilitation 3Palliative Care 3Metformin 3Exercise Test 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Motor Activity × Ipilimumab × Clear all
NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Active not recruiting
22 enrolled
Dermatologic

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Recruiting
160 enrolled
Dermatologic

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡